April 2001
BEECHWOOD SURGERY
NEWPORT
SOUTH WALES
To audit the current level of cholesterol control in patients with Ischaemic Heart Disease who are currently taking lipid lowering medication.
Criteria: Patients to have a confirmed diagnosis of IHD
To be currently on repeat prescription for lipid lowering
Medication
Standard: To maintain cholesterol level to below 5mmol (LDL to < 3mmols)
Or by 30% whichever is the greater
As per N.S.F framework – Coronary Heart Disease
A computer search revealed that 191 patients with a diagnosis of ischaemic heart disease are currently prescribed lipid lowering medication.
Of these: MALE ® 121
> 191
FEMALE ® 70
For the purposes of this audit only the male population was considered, and of these 25% (30) were selected at random to audit current cholesterol level control.
Of the 121 men:
of the remaining 44 patients
Statins/Fibrates currently used:
Of the 25% i.e. 30 patients taken from the search to assess cholesterol maintenance level – the last recorded result showed the following
Cholesterol level < 5.0mmol = 22 patients
4.5 – 4.9mmol = 12
Of these: 20 attended IHD Clinic
4.0 – 4.4mmol = 7 > 1 attends the Diabetic Clinic
< 3.9mmol = 3 1 attends neither
Cholesterol level > 5.0mmol = 8 patients
3 x IHD Clinic patients ® 1. 5.6mmol – has had statin increased, due follow up
2. 5.6mmol – " " " " " " "
3. 5.2mmol - " " " " " " "
3 x Diabetic patients ® Surgery – 6.6mmol
5.6mmol - also under care of RGH
2 x c/o RGH ® Cardiologist 5.7mmol
x 1 ? no record in surgery notes – did not reply to IHD invitation
Conclusion/Forward Planning
under any review
having present levels > 5.0mmol
for one month only